Cargando…
Autophagy Inhibition Enhances the Anti-Tumor Activity of Methylseleninic Acid in Cisplatin-Resistance Human Lung Adenocarcinoma Cells
Cisplatin (DDP)-based chemotherapy remains one of the standard treatment options for patients with advanced lung adenocarcinoma (LUAD), and cisplatin resistance is the biggest challenge to this therapy. Autophagy is also closely associated with chemoresistance in LUAD. Desperately need to find a way...
Autores principales: | Xin, Ming, Gao, Qi, Xiang, Xindong, Xu, Juanjuan, Jiao, Yuhan, Li, Xuan, Zhang, Xianzhen, Jia, Xiuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110759/ https://www.ncbi.nlm.nih.gov/pubmed/35592418 http://dx.doi.org/10.3389/fphar.2022.890974 |
Ejemplares similares
-
Inhibition of autophagy potentiates the cytotoxicity of the irreversible FGFR1-4 inhibitor FIIN-2 on lung adenocarcinoma
por: Jia, Xiuqin, et al.
Publicado: (2022) -
Polyphyllin II induced apoptosis of NSCLC cells by inhibiting autophagy through the mTOR pathway
por: Jiao, Yuhan, et al.
Publicado: (2022) -
EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2021) -
Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020) -
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017)